ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,510,490 | +12.2% | 1,001,000 | +8.8% | 1.52% | +7.3% |
| Q2 2023 | $18,280,400 | +16.0% | 920,000 | 0.0% | 1.41% | +35.9% |
| Q1 2023 | $15,759,600 | -5.3% | 920,000 | +8.2% | 1.04% | +0.1% |
| Q4 2022 | $16,634,500 | +64.7% | 850,000 | +34.3% | 1.04% | +115.6% |
| Q3 2022 | $10,100,000 | +16.0% | 632,822 | 0.0% | 0.48% | +12.4% |
| Q2 2022 | $8,708,000 | -10.4% | 632,822 | +3.3% | 0.43% | -16.4% |
| Q1 2022 | $9,719,000 | -27.4% | 612,822 | 0.0% | 0.51% | -19.0% |
| Q4 2021 | $13,378,000 | -16.2% | 612,822 | +14.7% | 0.63% | -23.4% |
| Q3 2021 | $15,964,000 | – | 534,085 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |